Skip header and navigation

6 records – page 1 of 1.

Nova Scotia Health Authority. Central Zone. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
0249
Available Online
View Pamphlet
This pamphlet will inform the reader about clopidogrel and how to use it. The pamphlet explains what this medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Anticoagulants
Subjects (LCSH)
Anticoagulants (Medicine)
Specialty
Medications
Abstract
This pamphlet will inform the reader about clopidogrel and how to use it. The pamphlet explains what this medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0249
Less detail

Handbook of oral anticoagulation

https://libcat.nshealth.ca/en/permalink/provcat33540
editors, Gregory YH Lip, Eduard Shantsila ; contributors, Deirdre A. Lane, Chee W. Khoo, Kok Hoon Tay, Suresh Krishnamoorthy, Stavros Apostolakis. (Second edition) --London: Springer Healthcare , c2013.
Available Online
View e-Book
Location
Online
This book covers a wide range of disorders such as atrial fibrillation, artificial heart valves, deep vein thrombosis, pulmonary embolism and stroke. Handbook of Oral Anticoagulation aims to provide an accessible overview of the exciting new developments in this field. Incorporating numerous quick-reference tables and figures and fully referenced throughout to key papers and the latest reviews, it will be a useful resource for all healthcare professionals involved in thromboprophylaxis.
Available Online
View e-Book
Other Authors
Lip, Gregory Y. H
Shantsila, Eduard
Responsibility
editors, Gregory YH Lip, Eduard Shantsila ; contributors, Deirdre A. Lane, Chee W. Khoo, Kok Hoon Tay, Suresh Krishnamoorthy, Stavros Apostolakis
Edition
Second edition
Place of Publication
London
Publisher
Springer Healthcare
Date of Publication
c2013
Physical Description
1 online resource (ix, 88 pages)
ISBN
9781908517968 (electronic bk.)
9781908517586
Subjects (MeSH)
Anticoagulants - administration & dosage
Anticoagulants - adverse effects
Anticoagulants - therapeutic use
Subjects (LCSH)
Anticoagulants - Handbooks
Anticoagulants (Medicine)
Cardiology
Hematology
General Practice / Family Medicine
Primary Care Medicine
Pharmacotherapy
Abstract
This book covers a wide range of disorders such as atrial fibrillation, artificial heart valves, deep vein thrombosis, pulmonary embolism and stroke. Handbook of Oral Anticoagulation aims to provide an accessible overview of the exciting new developments in this field. Incorporating numerous quick-reference tables and figures and fully referenced throughout to key papers and the latest reviews, it will be a useful resource for all healthcare professionals involved in thromboprophylaxis.
Contents
The Coagulation Pathway and Approaches to Anticoagulation -- Common Clinical Indications for Anticoagulation -- Vitamin K Antagonists and Their Limitations -- Hemorrhage Risks, Patient Perspectives, and Quality-of-Life Issues -- New Oral Anticoagulants -- Future Directions.
Format
e-Book
Location
Online
Less detail

Heparin to prevent clotting during hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35407
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1494
Available Online
View Pamphlet
This pamphlet explains how heparin can help a person with kidney disease who is on hemodialysis. This medicine helps people with kidney disease by preventing blood from clotting in the dialysis lines during hemodialysis. How to take the medicine and what side effects to watch for are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Heparin - therapeutic use
Anticoagulants - therapeutic use
Subjects (LCSH)
Heparin
Anticoagulants (Medicine)
Hemodialysis
Specialty
Nephrology
Medications
Abstract
This pamphlet explains how heparin can help a person with kidney disease who is on hemodialysis. This medicine helps people with kidney disease by preventing blood from clotting in the dialysis lines during hemodialysis. How to take the medicine and what side effects to watch for are reviewed.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1494
Less detail
Nova Scotia Health Authority. QEII. Cardiology. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1496
Available Online
View Pamphlet
Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Cardiology
Alternate Title
Brilinta
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Platelet Aggregation Inhibitors - therapeutic use
Adenosine - therapeutic use
Cardiovascular Diseases - prevention & control
Myocardial Infarction - prevention & control
Pulmonary Embolism - prevention & control
Subjects (LCSH)
Adenosine
Anticoagulants (Medicine)
Cardiovascular system--Diseases--Prevention
Myocardial infarction--Prevention
Abstract
Ticagrelor is a medicine used along with low dose Aspirin to reduce your risk of having a heart attack. You should not take Ticagrelor if you have or had a current bleeding problem such as bleeding from a stomach ulcer or if you have severe liver disease. Instructions for how to take and store this medicine as well as drug interactions and foods to avoid are discussed. Missed dose instructions are given. This pamphlet also describes warnings and possible side effects.
Responsibility
Prepared by: Cardiology
Pamphlet Number
1496
Less detail

Warfarine sodique

https://libcat.nshealth.ca/en/permalink/chpams36661
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
2063
Available Online
View Pamphlet
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également f…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Alternate Title
Coumadin
Warfarin sodium
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
French
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Warfarin
Anticoagulants
Subjects (LCSH)
Warfarin
Anticoagulants (Medicine)
Abstract
Cette brochure fournit des instructions précises aux patients qui prennent de la warfarine et qui sont traités pour au moins un des problèmes médicaux suivants : fibrillation auriculaire ou atriale (rythme cardiaque irrégulier), valvule prothétique (artificielle), thrombose veineuse (caillot de sang dans une veine profonde) ou embolie pulmonaire (artère du poumon bloquée par un caillot de sang), infarctus du myocarde (crise cardiaque) ou autre problème connexe. Des instructions sont également fournies sur la façon de prendre le médicament, les doses manquées, les analyses sanguines RIN (ou INR), les interactions médicamenteuses et alimentaires, les effets secondaires et les mesures de sécurité. Vous y trouverez aussi des numéros où appeler si vous avez des questions.
This is a French translation of the English pamphlet 0373 “Warfarin Sodium". This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and food interactions, side effects, and safety precautions are provided. Contact numbers are also given if you have questions.
Responsibility
Prepared by: Pharmacy Services ; Revised by: Hematology Services, QEII
Pamphlet Number
2063
Less detail
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
0373
Available Online
View Pamphlet
This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Alternate Title
Coumadin
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Warfarin
Anticoagulants
Subjects (LCSH)
Warfarin
Anticoagulants (Medicine)
Abstract
This pamphlet gives specific directions if you are a patient on warfarin and you are undergoing treatment for at least one of the following conditions: atrial fibrillation (irregular heartbeat), prosthetic (artificial) heart valve, venous thrombosis (blood clot in a deep vein) or pulmonary embolism (artery in the lung blocked by a blood clot), myocardial infarction (heart attack), or another related condition. Directions about how to take this medication, missed doses, INR blood tests, drug and food interactions, side effects, and safety precautions are provided. Contact numbers are also given if you have questions. The French translation of this pamphlet 2063, "Warfarine sodique" is also available.
Notes
Previous title: Warfarin sodium, an oral anticoagulant
Responsibility
Prepared by: Pharmacy Services ; Revised by: Hematology Services, QEII
Pamphlet Number
0373
Less detail

6 records – page 1 of 1.